FUJIFILM Biosciences

With a foundation in cell culture that dates back to 1970, FUJIFILM Biosciences is a global, full spectrum supplier to the life sciences market, providing products and services that assist customers in advancing healthcare initiatives. With an expanding portfolio of applications supported that include life science and discovery research, cell and gene therapy, as well as the large-scale production of biotherapeutics and vaccines, the Company is trusted by researchers and manufacturers worldwide.

For over 50 years, FUJIFILM Biosciences’ Mission has been to empower all who bring medicines and treatments to life with unmatched quality and responsiveness in its products and custom solutions, providing customers with the vital resources needed to enrich human lives through innovative, accessible therapies. The Company’s facilities adhere to both ISO and FDA regulations, with manufacturing facilities that follow cGMP guidelines in the USA, Japan, and the Netherlands, and a media optimization center in China.

All sites prioritize strategies that adhere to the FUJIFILM Sustainability Value Plan 2030 for sustainable growth. FUJIFILM Biosciences is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.

For more information, please visit: fujifilmbiosciences.fujifilm.com

FEATURED INSIGHTS

Chemically Defined Medium For Intensified AAV And LV Production In HEK293 Cells
Discover how a chemically defined medium designed for suspension HEK293 perfusion cultures supports intensified AAV and LV production processes, with viable cell densities exceeding 10^8 cells/mL.
How Raw Materials, Media Composition, And Process Decisions Shape Advanced Cell Therapies
Learn how variability in patient-derived starting materials, serum dependence, cytokine selection, and platform lock-in create downstream risks that proactive process design can help prevent.
Predicting The Performance Of Perfusion Media In A Continuous Bioreactor
Small-scale perfusion-mimic models can effectively predict media performance in continuous bioreactors to help optimize cell density, productivity, and scalability for CHO cell lines.
High-Throughput Screening For High-Performance Cell Culture Media Development
Learn about a high-throughput screening method that successfully optimized cell culture media, leading to a greater than 3-fold improvement in viral genome titer for AAV2 production.
Advanced Approaches For Developing And Optimizing Perfusion Platforms
Discover how to effectively use small-scale perfusion-mimic systems to identify optimal cell culture media and significantly increase volumetric productivity for large-scale biomanufacturing.
Scalable Strategies For Intensified Viral Vector Production In HEK293 Cell Culture
Learn a strategy for scalable bioprocessing and media optimization that drives intensified viral vector production. Achieve high cell density, excellent viability, and consistent AAV titers from 50mL to 5L.
Chemically Defined HEK293 Viral Feed Boosts Viral Vector Production
Discover how a chemically defined viral feed can boost AAV titers by up to 8-fold, supporting multiple serotypes and both suspension and adherent HEK293 cell lines, simplifying scalability.

CONTACT INFORMATION

FUJIFILM Biosciences

1830 E. Warner Avenue

Santa Ana, CA 92705-5505

UNITED STATES

Phone: 949-261-7800

Fax: 949-261-6522

Request More Information

Visit Our Website

NEWS

SOLUTIONS

Achieve A New Level Of Viral Vector Productivity

Maximize your viral vector output with a chemically defined medium engineered for high cell density HEK293 perfusion and intensified processes, optimizing efficiency and product integrity.

What Is Oceo Rover? A Platform Solution To Deliver Consistent Solutions On Demand

Automated buffer and media preparation is reshaping bioprocessing operations, offering over 50% time savings, reduced labor demands, and safer floor-level handling compared to traditional methods.
Oceo Rover: Automated Hydration System

Learn about an automated hydration system that replaces manual powder prep with a closed-loop, single-use skid designed to cut turnaround times and reduce contamination risk in bioprocessing.
Accelerate Development With AdaptPD CHO-MK Platform Media

A novel CHO-MK cell culture medium and feed system designed for fed-batch biologics production, delivering titers up to 12 g/L in 4 to 7 days and 2 to 3x productivity gains over conventional methods.
BalanCD CHO Feed 4 Evo: An Enhanced Feed for Evolving mAb Process Platforms

Scale up mAb production with confidence using an evolved CHO feed that simplifies hydration to three steps, improves media stability, and delivers consistent titers across multiple CHO subtypes.
Support Consistent Research With Defined Umbilical Cord-Derived MSCs

Consistent MSC research starts with controlling variability. Cell sourcing and optimized cryopreservation strategies can improve process control for umbilical cord-derived cell therapy development.
Enable Your Perfusion Process And Maximize Productivity

Support the growth and productivity of CHO cells in perfusion culture systems with a chemically defined, complete, and ready-to-use medium.
Complete Cell Culture Media Solutions For Primary Mesenchymal Stromal/Stem Cells

Optimize your mesenchymal stromal/stem cell (MSC) workflow with advanced media for robust expansion, reliable differentiation, and preserved cell viability post-cryopreservation.
Performance-Optimized Solutions For MSC Expansion

This xeno- and serum-free media and supplement pairing provides consistent, high-yield expansion of MSCs from various tissue sources while maintaining their critical phenotype.